TRI Auditorium
09 Oct 2019 8:00am to 9:15am

TRI Forum 3: The Dilemmas of Governance and Translational Trials

The delays in getting clinical trials going are causing distress to the investigators and patients; chewing up both human and financial resources; and ultimately delaying, sometimes by years, the time it takes to get a health improvement into practice. Governance requirements are one of the major causes of these delays.  Find out what they are doing at Harvard to overcome these issues, and what Queensland can do, at a seminar and forum featuring Professor Barbara Bierer, Professor of Medicine, Harvard Medical School.

Professor Bierer is co-founder and head of the Multi-Regional Clinical Trials Centre of Brigham and Women’s Hospital and Harvard, a collaborative effort to improve standards for the planning and conduct of international clinical trials; and Director of the Regulatory Foundations, Ethics, and the Law program at the Harvard Catalyst.  She is also Director of Regulatory Policy for SMART IRB, a national effort to align single site IRB review of multi-site trials.

Prof Bierer will chair the Forum and will be discussing these challenges with presentations from a Clinician Investigator, a Researcher, Research Partnership Manager at a University and a Director of Research at a Hospital.  These presentations will be followed by a panel discussion and also an opportunity for questions from the audience.

Wednesday 9 October 
TRI Atrium - 7:30am Breakfast  
TRI Auditorium – 8.00am Forum Opens and finishes at 9.15am

This is a registration only event – please RSVP to [email protected] by Friday 4th October.  

Professor Bierer will also present a seminar at TRI on Tuesday 8th October from 5pm in the auditorium, giving an in depth lecture about her experience, challenges and findings. To find out more about the forum and to register, please see here